HighTower Advisors’s Amgen AMGN Stock Holding History

HighTower Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-900	Closed	-$873	–	3762
2025 Q1	$873	Buy	+900	New	+$266K	﹤0.01%	3658
2024 Q4	–	Sell	-35,100	Closed	-$197K	–	3811
2024 Q3	$197K	Buy	+35,100	New	+$11.5M	﹤0.01%	3136
2024 Q1	–	Sell	-800	Closed	-$241	–	3620
2023 Q4	$241	Buy	+800	New	+$218K	﹤0.01%	3596
2023 Q3	–	Sell	-2	Closed	-$512	–	3567
2023 Q2	$512	Sell	2 -198	-99%	-$45.9K	﹤0.01%	3404
2023 Q1	$850	Buy	200 +198	+9,900%	+$48.6K	﹤0.01%	3314
2022 Q4	$3.42K	Buy	+2	New	+$536	﹤0.01%	3240
2022 Q2	–	Sell	-11	Closed	-$1K	–	3232
2022 Q1	$1K	Sell	11 -10	-48%	-$2.3K	﹤0.01%	3354
2021 Q4	$34K	Sell	21 -1,879	-99%	-$397K	﹤0.01%	3059
2021 Q3	$2K	Buy	1,900 +300	+19%	+$69K	﹤0.01%	3093
2021 Q2	$1K	Buy	1,600 +1,581	+8,321%	+$389K	﹤0.01%	3091
2021 Q1	$2K	Buy	+19	New	+$4.53K	﹤0.01%	2980

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HighTower Advisors's AMGN Position: Q1 2026 in Review

HighTower Advisors increased its Amgen (AMGN) stake by 4.3% in Q1 2026, buying an estimated $12M and bringing the position to 820,320 shares worth $289M. The position accounts for 0.31% of the portfolio, ranked #61.

HighTower Advisors first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

HighTower Advisors held 820,320 shares of Amgen worth $289M as of Q1 2026.
HighTower Advisors bought 33,696 Amgen shares in Q1 2026, an estimated $12M.
Amgen made up 0.31% of HighTower Advisors's portfolio in Q1 2026, its #61 holding.
HighTower Advisors first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.